| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.7M | -1.4% |
| Cost of Revenue | $3.1M | -21.1% |
| Gross Profit | $5.7M | +13.9% |
| R&D Expense | $3.2M | -40.8% |
| SG&A Expense | $13.5M | -21.7% |
| Operating Income | -$11.0M | +37.7% |
| Pre-tax Income | -$11.2M | +44.8% |
| Income Tax | $5K | -37.5% |
| Net Income | -$11.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.1M | +34.1% |
| Accounts Receivable | $1.7M | -11.5% |
| Inventory | $1.7M | -14.0% |
| Current Assets | $8.9M | +7.9% |
| Total Assets | $9.9M | +1.0% |
| Current Liabilities | $2.6M | -19.3% |
| Total Liabilities | $3.3M | -49.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.6M | +46.5% |
| Capital Expenditures | $60K | -59.7% |
| Investing Cash Flow | -$60K | -118.2% |
| Financing Cash Flow | $11.0M | +197.6% |
| Free Cash Flow | -$9.7M | +46.6% |
| +44.8% |
| EPS (Basic) | -$8.41 | +27.0% |
| EPS (Diluted) | -$8.41 | +27.0% |
| Stockholders' Equity |
| $6.5M |
| +118.3% |